
Simtuzumab
CAS No. 1318075-13-6
Simtuzumab( —— )
Catalog No. M36673 CAS No. 1318075-13-6
Simtuzumab is a monoclonal antibody against lysyl oxidase-like protein 2 (LOXL2).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 337 | Get Quote |
![]() ![]() |
5MG | 535 | Get Quote |
![]() ![]() |
10MG | 867 | Get Quote |
![]() ![]() |
25MG | 1260 | Get Quote |
![]() ![]() |
50MG | 1702 | Get Quote |
![]() ![]() |
100MG | 2241 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameSimtuzumab
-
NoteResearch use only, not for human use.
-
Brief DescriptionSimtuzumab is a monoclonal antibody against lysyl oxidase-like protein 2 (LOXL2).
-
DescriptionSimtuzumab (AB 0024; GS 6624) is a monoclonal antibody directed against Lysyl oxidase like-2 (LOXL2). Simtuzumab can be used for the research of primary sclerosing cholangitis (PSC).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetMonoamine Transporter
-
RecptorMonoamine Oxidase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1318075-13-6
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wei Chen, et al. Lysyl Oxidase (LOX) Family Members: Rationale and Their Potential as Therapeutic Targets for Liver Fibrosis. Hepatology. 2020 Aug;72(2):729-741.?
molnova catalog



related products
-
Paroxetine hydrochlo...
An antidepressant of the selective serotonin reuptake inhibitor (SSRI) class.
-
Edivoxetine hydrochl...
Edivoxetine (LY2216684) is a novel potent, selective norepinephrine reuptake inhibitor (NERI) being evaluated as adjunctive treatment for major depressive disorder (MDD).
-
Nisoxetine hydrochlo...
Nisoxetine hydrochloride is a noradrenaline transporter (NET) inhibitor.